Progressive kidney diseases and renal fibrosis are associated with endothelial injury and capillary rarefaction. However, our understanding of these processes has been hampered by the lack of tools enabling the quantitative and noninvasive monitoring of vessel functionality. Here, we used micro-computed tomography (mCT) for anatomical and functional imaging of vascular alterations in three murine models with distinct mechanisms of progressive kidney injury: ischemia-reperfusion (I/R, days 1-56), unilateral ureteral obstruction (UUO, days 1-10), and Alport mice (6-8 weeks old). Contrast-enhanced in vivo mCT enabled robust, noninvasive, and longitudinal monitoring of vessel functionality and revealed a progressive decline of the renal relative blood volume in all models. This reduction ranged from 220% in early disease stages to 261% in late disease stages and preceded fibrosis. Upon Microfil perfusion, high-resolution ex vivo mCT allowed quantitative analyses of three-dimensional vascular networks in all three models. These analyses revealed significant and previously unrecognized alterations of preglomerular arteries: a reduction in vessel diameter, a prominent reduction in vessel branching, and increased vessel tortuosity. In summary, using mCT methodology, we revealed insights into macro-to-microvascular alterations in progressive renal disease and provide a platform that may serve as the basis to evaluate vascular therapeutics in renal disease.
Here, we show that the combination of functional in vivo mCT with high-resolution anatomical ex vivo mCT enables a detailed, robust, and accurate assessment of macro-to-microvascular changes during early-to-late-stage progressive kidney disease. We applied contrast-enhanced in vivo mCT to determine the renal relative blood volume (rBV), which is defined as the percentage of the blood volume to the total organ volume. 20 Subsequently, we performed Microfil perfusion and high-resolution ex vivo mCT imaging to determine branching, size and tortuosity of renal blood vessels (Figure 1 ). To model a broad spectrum of renal diseases, address potential disease-specific differences and describe the time-dependent dynamics of vascular alterations and their association with renal fibrosis, we have used three distinct models: unilateral ischemia-reperfusion-induced progressive kidney injury (I/R), a primary model of interstitial fibrosis, namely unilateral ureteral obstruction (UUO) and a model of progressive glomerulonephritis, namely Col4a3-deficient (Alport) mice ( Figure 1 ).
RESULTS

Peritubular Capillary Rarefaction Correlates with Fibrosis in Chronic Kidney Disease Models
First, we analyzed mice with I/R-induced injury and monitored the entire time course from acute ischemic injury (day 1) to late-stage renal fibrosis (day 56). 14, 21 Histologically, a continuous increase of collagen I, fibronectin, and a-smooth muscle actin (aSMA)-positive fibroblasts confirmed the development of progressive fibrosis and was paralleled by a continuous decrease of Meca-32-positive capillaries ( Figure 2 , A and B). Significant correlations between these parameters demonstrated an association between progressive fibrosis and capillary loss ( Figure 2 , B and C). Importantly, the prominent early reduction of Meca-32 positive peritubular capillaries in I/R injury, found already on day 1, preceded the onset of fibrosis.
In order to exclude model-specific effects related to I/Rinduced progressive kidney injury, the correlation between progressive fibrosis and continuous vessel rarefaction was histologically confirmed in UUO (days [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] and Alport mice (6-8 weeks) . Comparable to the time-course findings obtained in the I/R model, a prominent early reduction of Meca-32 positive cortical peritubular capillaries on day 3 also preceded the onset of significant fibrosis, as found on day 5 in the UUO model ( Figure 3A) . Analogously, also in Alport mice, progressive loss of Meca-32 positive capillaries was paralleled by fibrosis development ( Figure 3B ).
Functional In Vivo mCT Imaging Allows Accurate Assessment of Reduced Vessel Functionality in Chronic Kidney Disease Models To monitor renal blood vessels during the progression of renal disease, we employed a contrast-enhanced mCT approach for in vivo imaging using an iodine-based contrast agent optimized for blood-pool imaging. 18 This approach enabled the noninvasive visualization of renal vessels with a spatial resolution of 35 mm voxel side length, as exemplified by cross-sectional images and 3D renderings ( Figure 4A ). Longitudinal in vivo mCT scans of mice with I/R-induced kidney injury confirmed the significant loss of functional blood vessels already at early time points after I/R injury and an even more pronounced rarefaction in late-stage fibrosis ( Figure 4B , Supplemental Videos 1 and 2). Accordingly, renal rBV values decreased already early (220% on I/R day 1) and progressively (up to 243% on I/R day 56, compared with baseline renal rBV values quantified in sham controls), demonstrating that fibrosis progression was paralleled by a gradual loss of vessel functionality (P,0.001; Figure  4C ). Similar to the histologic findings, the reduction in functional vessels assessed by in vivo mCT was observed before the onset of interstitial fibrosis ( Figure 2B ). 7, [22] [23] [24] We confirmed the continuous reduction of vessel functionality in Alport and UUO mice. For both models, in vivo mCT showed significantly reduced rBV values in diseased versus control kidneys ( Figure 5 , A and B for UUO; Figure 5 , D and E for Alport mice, respectively). Strikingly, in the UUO model, capillary rarefaction and the gradual loss of vessel functionality were also observed very early, before the onset of overt fibrosis, i.e., on day 3 ( Figures 3A and 5B) .
To assess the accuracy of in vivo mCT for quantifying vascular dysfunction in kidney fibrosis, rBV values were correlated with histologically reconstructed equivalents (Supplemental Figure  1) . 18 As exemplified by the I/R model, a significant correlation between rBV values determined by in vivo mCT and immunohistochemistry was observed (R 2 =0.98, P,0.001, Figure 4D ). This high congruency was also found in the UUO model and in Alport mice ( Figure 5 , C and F, respectively). Within all the experiments, quantified renal rBV values were extremely consistent and showed very low variability in both healthy and diseased animals, further corroborating the high accuracy and robustness of our methodology.
Renal rBV in contralateral (right) kidneys of mice with I/R or UUO supported the progressive course of kidney damage in the injured (left) kidneys. Renal rBV was significantly increased in the contralateral kidneys from day 14 in I/R and day 7 in UUO mice onwards (+17% at I/R day 56 and +21% at UUO day 10; Supplemental Figure 2 , A and B), suggesting a compensatory hypertrophy of these kidneys. The total kidney volume of contralateral kidneys correspondingly increased during disease progression (Supplemental Figure 3, A and B) . The injured left kidneys in I/R mice also showed an initial increase in organ volume, most likely due to post-ischemic swelling (I/R day 1-3), followed by continuous organ shrinkage from day 5 onwards. In UUO, as expected due to the progression of hydronephrosis, kidney volumes continuously increased (Supplemental Figure 3B ).
Anatomical Ex Vivo mCT Imaging Reveals Macro-toMicrovascular Alterations in Chronic Kidney Disease Models Upon in vivo imaging, mice were perfused with the vascular casting agent Microfil, 18 and subsequently performed high-resolution mCT scans of excised kidneys resulted in a spatial resolution of approximately 3 mm voxel side length. Previous studies have reported on Microfil perfusion of the renal vasculature in mice and rats. [25] [26] [27] [28] Here, we used this highresolution ex vivo mCT method to analyze vessel morphometrics that can be derived from perfused renal vasculature, such as branching, size and tortuosity, in progressive kidney fibrosis.
After threshold-based vessel tree segmentation, compared with healthy controls, a significant loss of small-caliber arterial vessels was observed in fibrotic kidneys (Figures 6A, 7A and 8A; Supplemental Videos 3 and 4). When analyzing vascular branching in detail, the reduction of the renal rBV in progressive kidney fibrosis ( Figure 4C ) was morphologically linked to a strong reduction of peripheral branching points: i.e., in I/R day 14 kidneys, the number of 4th (Aa. interlobulares) and 5th order (afferent arterioles) branching points significantly decreased by 238% and 274%, respectively (P,0.001; Figure  6B ). The number of peripheral branching points progressively Figure 1 . Experimental outline for anatomical and functional imaging of the renal vasculature during progressive kidney diseases. Three different murine models were investigated: I/R, Col4A3-deficient (Alport) mice and UUO. Using contrast-enhanced in vivo mCT, the renal relative blood volume (rBV) was determined noninvasively by quantifying the radiodensity of five spherical volumes of interests (VOIs) per kidney cortex. Upon Microfil perfusion, the 3D microarchitecture of the renal vasculature was visualized by high-resolution ex vivo mCT at a spatial resolution of 3 mm voxel side length, enabling the quantitative assessment of vessel branching, diameter and tortuosity in strict hierarchical order from the hilus (Aa. segmentales) to the periphery (afferent arterioles). Arrows demonstrate the order of rising branching points along the course of blood vessels. Vessel tortuosity was calculated as a ratio of the vessel length between two nearby branching points and the linear distance between those. CTRL, contralateral kidney.
decreased until day 21 with up to 260% and 289% reduction of 4th and 5th order branching points, respectively (P,0.001, Figure 6B ). High-resolution mCT imaging revealed similar findings for Alport kidneys ( Figure 7 , A and B) and an even more pronounced reduction in UUO with up to 268% and 291% reductions for 4th and 5th order branching points, respectively (P,0.001; Figure 8 , A and B). Importantly, branching points of large-caliber arterial vessels (Aa. segmentales, interlobares and arcuatae) were not altered. These findings indicate that independently of the underlying disease, kidney injury is not only associated with the well-described rarefaction of peritubular capillaries 1, 14, 29, 30 but also with a pronounced rarefaction of functional small-caliber arteries (from Aa. interlobulares downward). Surprisingly, when quantifying the size of renal vessels, a yet unrecognized reduction of luminal diameter of all large-tosmall-sized arterial vessels during disease progression was observed. As exemplified by I/R day 14, a massive reduction in diameters of Aa. segmentales (214%), interlobares (221%), arcuatae (230%), interlobulares (236%), and afferent arterioles (222%) was found compared with sham-treated controls (P,0.001; Figure 6C) . Strikingly, vessel diameters were not further reduced beyond day 14, even though fibrosis and vessel rarefaction progressed. A similar reduction of arterial vessel diameters was confirmed in Alport and UUO kidneys (Figures 7C and 8C) .
To extend these analyses, we also quantified vessel tortuosity, i.e., the ratio of the vessel length between two nearby branching points and the linear distance between these two (see Figure 1 ). In line with observed reductions in vessel size and branching points, a clear increase in vessel tortuosity was observed in all three models during fibrosis progression. In I/R day 14, an increase in vessel tortuosity was observed in Aa. interlobares (+4%), arcuatae (+6%), interlobulares (+11%), and afferent arterioles (+16%; P,0.001; Figure  6D ). Beyond I/R day 14, tortuosity further increased in Aa. interlobulares and afferent arterioles (+14% and +21%, respectively; P,0.0001). mCT-based determinations of vessel tortuosity in Alport kidneys revealed similar findings ( Figure 7D ) and again an even stronger effect in UUO kidneys with increased tortuosity by +18% for Aa. arcuatae, +18% for Aa. interlobulares and +28% for afferent arterioles (P,0.001; Figure 8D) . Collectively, these findings exemplify that high-resolution mCT is highly suitable for a comprehensive assessment of vascular alterations and revealed significant changes in vessel branching, diameter, and tortuosity during the progression of kidney diseases.
DISCUSSION
Endothelial injury resulting in capillary rarefaction has been identified as a hallmark of CKD development. [1] [2] [3] [4] [5] [6] [7] Several recent studies suggested that restoring the renal microvasculature may provide novel therapeutic options for patients with CKD. [8] [9] [10] [11] [12] Thus far, however, quantitative imaging tools allowing for the noninvasive monitoring of morphologic and functional alterations of the renal microvasculature during disease progression have been lacking, and studies investigating vessel rarefaction in CKD have been largely restricted to invasive microscopic end-point analyses. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] We here employed in vivo and ex vivo mCT-based imaging techniques, alongside conventional immunohistochemical methodologies, to demonstrate that (1) contrast-enhanced in vivo mCT imaging is highly suitable for accurate and noninvasive monitoring of vessel functionality during progressive kidney diseases, via quantifying the renal rBV; (2) the renal rBV continuously decreases during early-to-late-stage renal disease progression; (3) vessel functionality is reduced immediately after renal injury prior to the onset of interstitial fibrosis, supporting the assumption that endothelial injury might be a major initiating cause of fibrosis development; and (4) in addition to peritubular capillaries, arterial vessels of virtually all calibers undergo substantial alterations during progressive renal disease with regard to vessel branching, size, and tortuosity.
Prior studies using tissue samples from patients and various CKD animal models have shown that fibrosis progression is associated with a continuous rarefaction of glomerular and cortical peritubular capillaries. 1, [31] [32] [33] [34] [35] Previous publications also reported on different invasive in situ preparation techniques to assess vascular parameters such as renal blood flow, flow velocity, and vessel diameter in experimental kidney injury models in rats. [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] However, highly detailed longitudinal analyses on vessel functionality in experimental mouse models of chronic kidney diseases have not been performed to date. To bridge this gap, we refined a recently described contrast-enhanced mCT-based imaging protocol enabling the noninvasive visualization and quantification of microvascular changes in tumors and in liver fibrosis 18, 19 for monitoring vessel functionality in experimental models of chronic kidney injury in mice. Using this technique, we confirm previous findings of peritubular capillary loss at the functional level in a quantitative, noninvasive, and longitudinal manner using renal rBV analyses.
Our approach also demonstrates that vessel functionality was reduced immediately after renal injury, in particular in the I/R injury model, i.e., prior to the onset of fibrosis. Our findings support the hypothesis that capillary rarefaction may be a potential initiating trigger of progressive kidney fibrosis. 1,2,14,30 However, reduced rBV values in the post-ischemic phase upon I/R injury, and perhaps also in the other models, could have also been due to vascular congestion and/or vasoconstriction resulting in reduced kidney perfusion. Although the current gold standard for determining capillary rarefaction, i.e., histologic analysis, showed a reduction in filled Meca-32 positive blood vessels, this effect might also have been due to potential alterations in endothelial Meca-32 expression in response to cellular stress in the post-ischemic phase rather than loss of capillaries. 14,47-50 Importantly however, we observed a similar reduction in the number of capillaries in histologic analyses employing other endothelial markers, such as CD31 and VEGFR2 (J.B. and P.B., unpublished data).
We provide the first ex vivo images of the vascular network in healthy and diseased murine kidneys at a spatial resolution of less than 4 mm voxel side length, which extends previously published data on Microfil perfusion of the renal vasculature. [25] [26] [27] [28] In addition, the implementation of quantitative analyses of 3D vascular networks revealed a previously unrecognized reduction of vessel branches during disease progression paralleled by increased tortuosity of the remaining vessels. Extending previous studies, [51] [52] [53] we found that not only post-glomerular vessels, i.e., capillaries, but all large-to-small-sized blood vessels in the kidney exhibited substantially reduced luminal diameters during disease progression. This reduced diameter of Compared with other imaging modalities, computed tomography (CT) has several pros and cons. Pros include userfriendliness, operator independence, and the quantitative potential for both functional and anatomical characterization of vascular alterations in CKD. Cons include X-ray exposure, the need for iodine-based contrast agents and the low sensitivity of CT to contrast agents. 20 While the rBV determination is noninvasive and can be used longitudinally, the resolution of this approach does not allow detailed in vivo analyses of morphologic vascular changes such as branching, tortuosity or diameter. This is possible only using high-resolution ex vivo mCT imaging, which requires high X-ray doses and sacrifice of the animals. Another limitation of the in vivo mCT method is that it cannot distinguish between a structural loss of vessels versus a functional reduction of perfusion, e.g., due to vasoconstriction. Thus, this method provides a measure of functional renal vessels.
In summary, we here show that mCT imaging can be used to provide novel insights into the macro-to-microvascular alterations and dynamics in murine models of progressive renal diseases, including a previously unappreciated alteration of larger renal vessels. mCT imaging appears to be highly useful for the quantitative monitoring of anatomical and functional changes in the renal macro-and microvasculature, and might be particularly useful for studies on the role of blood vessels in CKD and for facilitating the bench-to-bedside translation of pro-angiogenic and anti-fibrotic therapies.
CONCISE METHODS
Kidney Injury Models
Chronic kidney injury was surgically induced in 6-week-old C57bl/6 wild-type mice by ischemia (30 min)/reperfusion injury (I/R) or unilateral ureteral obstruction (UUO) of the left kidney, as described previously. 29, 55 Sham-operated animals were used as controls. As a third model for progressive renal injury, 6-8-week-old Col4a3 2/2 mice bred on a 129/SvJ background, a model of Alport syndrome, were investigated alongside age-matched wild-type littermates. All mice were housed in a specific pathogen-free environment under ethical conditions approved by German legal requirements.
In Vivo Micro-Computed Tomography
Contrast-enhanced in vivo mCT imaging was performed using a dualenergy flat-panel micro-computed tomography scanner (TomoScope 30s Duo; CT Imaging, Erlangen, Germany). Mice were imaged before and immediately after intravenous injection of 100 ml eXIA TM 160XL
(Binitio Biomedical, Ottawa, Canada), a high molecular weight iodine-based contrast agent optimized for in vivo mCT-based blood pool imaging. The contrast agent was injected as a bolus into the lateral tail vein. During the entire in vivo imaging process, mice were anesthetized with 1.5% isoflurane in oxygen-enriched air. Dual-energy scans were performed at 41 and 65 kV (0.5 mA and 1 mA) resulting in 2880 projections of size 103231024 acquired over a 6-minute time frame. A Feldkamp-type algorithm (CT Imaging), including ring artifact correction, was applied to reconstruct volumetric data with a voxel size of 35335335 mm 3 . The reconstructed data were processed using Imalytics Preclinical software (Gremse-IT, Aachen, Germany) enabling the 3D visualization of blood vessels and interactive segmentation of volumes of interest (VOIs). Quantifications of the renal relative blood volume (rBV) were performed after defining five spherical (500 mm diameter) VOIs per kidney cortex. For each kidney, the rBV was calculated as the ratio of the contrast agent-induced enhancement (in Hounsfield units) of the renal cortex and the enhancement of pure blood which was measured in a large reference blood vessel (aorta) (Figure 1 ). 18 To quantify the total organ volume of kidneys, 3D mCT-based organ segmentations were performed.
Ex Vivo Micro-Computed Tomography
After in vivo mCT imaging, mice were perfused with Microfil (Flow Tech, Carver, MA), a lead-containing silicone rubber radiopaque contrast agent, by using constant flows adjusted via a perfusion pump (150 ml/h; catheter diameter: 1.0 cm; catheter length: 75 cm), as described previously in more detail. 18 Microfil, which solidifies approximately 20 min after application within the vascular compartment, enables the high-resolution 3D investigation of the microarchitecture of renal blood vessels. To this end, the excised kidneys were formalin-fixed and scanned using a high-resolution SkyScan 1172 mCT (SkyScan, Kontich, Belgium). In detail, kidneys were positioned on a rotation platform and scanned 180°around the vertical axis in rotation steps of 0.3°at 59 kVand an electric current of 167 mA. This resulted in 640 acquired projections (400032096 pixels) acquired over a period of 4-6 hours per kidney. Reconstructions were performed using filtered back-projection (Feldkamp-type) resulting in an isotropic pixel size of 3 mm. After 3D volume rendering of reconstructed high-resolution mCT data sets and threshold-based visualization of blood vessels, vascular branching as well as vessel size and tortuosity were semi-automatically analyzed as described in Figure 1 . In detail, vessel size and tortuosity were systematically determined by randomly choosing ten vessels per hierarchical order in the renal vessel tree (Aa. segmentales, interlobares, arcuatae, interlobulares and afferent arterioles). For each blood vessel, the diameter was determined in one of three possible (transversal, coronal or sagittal)
planes in which the cross-sectional area was relatively round and tortuosity was calculated as the ratio of the shortest vessel path length between two nearby branching points and the linear distance between these branching points. Normal anatomy of healthy kidneys confirmed our approach of tortuosity determination: compared with straight-running arteries, the more windy arcuate arteries showed the highest values for tortuosity ( Figures 6D, 7D and 8D ). Vascular branching patterns were analyzed by quantifying the number of branching points in total and per rising branching order per primary blood vessel along its course, from the hilus (Aa. segmentales) to the periphery (afferent arterioles) (see Figure 1 ).
Histology and Immunohistochemistry
Tissue sections were fixed using Methyl-Carnoy's solution and paraffin-embedded to assess renal morphology using periodic acidSchiff staining and to perform immunohistochemical stainings against collagen I, fibronectin, aSMA and Meca-32 using routine protocols. 55 In brief, sections were stained using primary antibody against murine collagen I (Southern Biotechnology Associates, Birmingham, AL), fibronectin (Chemikon International, Temecula, CA), aSMA (Dako, Glostrup, Denmark), and Meca-32 (Developmental Studies Hybridoma Bank at the University of Iowa, Iowa City, IA). Biotinylated secondary antibodies were purchased from Vector Laboratories (Burlingame, CA). Stained tissue slides were scanned using NanoZoomer digital slide scanner (Hamamatsu Photonics, Hamamatsu, Japan). For quantifying the degree of renal fibrosis, 16 photomicrographs (Original magnification,3400) were randomly taken per kidney cortex of each mouse (n=28 I/R, n=20 UUO, n=8 sham, n=10 Alport, and n=10 untreated wild-type mice). Area fractions of collagen I, fibronectin, aSMA, and filled Meca-32 positive blood vessels (see below) were quantified using open-access image analysis software ImageJ version 1.43u (National Institutes of Health, Bethesda, MD). For reconstructing the equivalent of in vivo quantified rBV values on 2D histologic slices, the lumen of Meca-32 positive vascular structures was computationally filled using three photomicrographs per kidney cortex, and the filled Meca-32 area fraction, which most closely reflects the vascular volume, was determined using a previously described custom macro implemented for ImageJ. 18 
Statistical Analysis
All data are presented as mean6SD. For assessing statistical significance, the two-tailed unpaired Student's t test and Pearson's correlation were used. P values ,0.05 were considered as statistically significant. All statistical analyses were performed using Graph PadPrism 5.0 (San Diego, CA).
